ArticleFrontiers in genetics2023

NR4A1 as a potential therapeutic target in colon adenocarcinoma: a computational analysis of immune infiltration and drug response.

Mei Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.